Lower serum uric acid and impairment of right cerebral hemisphere structural brain networks are related to depressive symptoms in cerebral small vessel disease : A cross-sectional study
© 2024 The Authors..
Cerebral small vessel disease (SVD) may be associated with an increased risk of depressive symptoms. Serum uric acid (SUA), an antioxidant, may be involved in the occurrence and development of depressive symptoms, but the mechanism remains unknown. Moreover, the relationship between structural brain networks and SUA has not been explored. This study examined the relationship between SUA and depressive symptoms in patients with SVD using graph theory analysis. We recruited 208 SVD inpatients and collected fasting blood samples upon admission. Depressive symptoms were assessed using the 24-item Hamilton Depression Rating Scale (HAMD-24). Magnetic resonance imaging was used to evaluate SVD, and diffusion tensor images were used to analyze structural brain networks using graph theory. Patients with depressive symptoms (n = 34, 25.76%) compared to those without (334.53 vs 381.28 μmol/L, p = 0.017) had lower SUA levels. Graph theoretical analyses showed a positive association of SUA with betweenness centrality, nodal efficiency, and clustering coefficients and a negative correlation with the shortest path length in SVD with depressive symptoms group. HAMD scores were significantly associated with nodal network metrics in the right cerebral hemisphere. Our findings suggested that lower SUA levels are significantly associated with disrupted structural brain networks in the right cerebral hemisphere of patients with SVD who have depressive symptoms.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Heliyon - 10(2024), 6 vom: 30. März, Seite e27947 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yu, Lei [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cerebral small vessel disease |
---|
Anmerkungen: |
Date Revised 22.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.heliyon.2024.e27947 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369994620 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369994620 | ||
003 | DE-627 | ||
005 | 20240323001435.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.heliyon.2024.e27947 |2 doi | |
028 | 5 | 2 | |a pubmed24n1341.xml |
035 | |a (DE-627)NLM369994620 | ||
035 | |a (NLM)38509880 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yu, Lei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lower serum uric acid and impairment of right cerebral hemisphere structural brain networks are related to depressive symptoms in cerebral small vessel disease |b A cross-sectional study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 22.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2024 The Authors. | ||
520 | |a Cerebral small vessel disease (SVD) may be associated with an increased risk of depressive symptoms. Serum uric acid (SUA), an antioxidant, may be involved in the occurrence and development of depressive symptoms, but the mechanism remains unknown. Moreover, the relationship between structural brain networks and SUA has not been explored. This study examined the relationship between SUA and depressive symptoms in patients with SVD using graph theory analysis. We recruited 208 SVD inpatients and collected fasting blood samples upon admission. Depressive symptoms were assessed using the 24-item Hamilton Depression Rating Scale (HAMD-24). Magnetic resonance imaging was used to evaluate SVD, and diffusion tensor images were used to analyze structural brain networks using graph theory. Patients with depressive symptoms (n = 34, 25.76%) compared to those without (334.53 vs 381.28 μmol/L, p = 0.017) had lower SUA levels. Graph theoretical analyses showed a positive association of SUA with betweenness centrality, nodal efficiency, and clustering coefficients and a negative correlation with the shortest path length in SVD with depressive symptoms group. HAMD scores were significantly associated with nodal network metrics in the right cerebral hemisphere. Our findings suggested that lower SUA levels are significantly associated with disrupted structural brain networks in the right cerebral hemisphere of patients with SVD who have depressive symptoms | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cerebral small vessel disease | |
650 | 4 | |a Depressive symptoms | |
650 | 4 | |a Diffusion tensor imaging | |
650 | 4 | |a Serum uric acid | |
650 | 4 | |a Structural brain networks | |
700 | 1 | |a Yi, Ming |e verfasserin |4 aut | |
700 | 1 | |a Guo, Jiayu |e verfasserin |4 aut | |
700 | 1 | |a Li, Jinbiao |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Huixing |e verfasserin |4 aut | |
700 | 1 | |a Cui, Liqian |e verfasserin |4 aut | |
700 | 1 | |a Xu, Xiangming |e verfasserin |4 aut | |
700 | 1 | |a Liu, Gang |e verfasserin |4 aut | |
700 | 1 | |a Fan, Yuhua |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Jinsheng |e verfasserin |4 aut | |
700 | 1 | |a Xing, Shihui |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yicong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Meng |e verfasserin |4 aut | |
700 | 1 | |a Tan, Shuangquan |e verfasserin |4 aut | |
700 | 1 | |a Jin, Leow Yi |e verfasserin |4 aut | |
700 | 1 | |a Kumar, Dilip |e verfasserin |4 aut | |
700 | 1 | |a Vipin, Ashwati |e verfasserin |4 aut | |
700 | 1 | |a Ann, Soo See |e verfasserin |4 aut | |
700 | 1 | |a Binte Zailan, Fatin Zahra |e verfasserin |4 aut | |
700 | 1 | |a Sandhu, Gurveen Kaur |e verfasserin |4 aut | |
700 | 1 | |a Kandiah, Nagaendran |e verfasserin |4 aut | |
700 | 1 | |a Dang, Chao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Heliyon |d 2015 |g 10(2024), 6 vom: 30. März, Seite e27947 |w (DE-627)NLM255913095 |x 2405-8440 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2024 |g number:6 |g day:30 |g month:03 |g pages:e27947 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.heliyon.2024.e27947 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2024 |e 6 |b 30 |c 03 |h e27947 |